Patrick Donnelly

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

May 14, 2018
The Power to See Differences that Matter
What are the real-world consequences of giving inadequate consideration to power when developing a… Read More
April 24, 2018
ProPharma Group Announces New President / CEO
ProPharma Group announces today that Dawn Sherman will be joining the company as President… Read More
April 3, 2018
Understanding the New Combination Product PMSR Guidance Documents and Impact…
Take a closer look at new FDA guidance documents surrounding postmarketing safety reporting (PMSR)… Read More
More Articles

UPCOMING Events

July 19, 2018
ISPE San Francisco Fun Day
Join ProPharma Group at the ISPE SF chapter’s 24th Annual Fun Day with a gold tournament and winery tour... Read More
August 23, 2018
ISPE Midwest Golf Tournament & Dinner
Join us at the ISPE Midwest Chapter’s Annual Golf Tournament and Dinner! This event is always a great af... Read More
September 24, 2018
PDA/FDA Joint Regulatory Conference
In keeping with the focus on putting patients first, this Conference will explore topics that ensure innovatio... Read More
All Events
Contact Us